Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines

Over the past 20 years, coronaviruses have caused three epidemics: SARS-CoV, MERS-CoV, and SARS-CoV2, with the first two having a very high lethality of about 10 and 26 %, respectively. The last outbreak of coronavirus infection caused by SARS-CoV2 in 2019 in China has swept the entire planet and is...

Full description

Saved in:
Bibliographic Details
Main Authors: N. R. Battulin, O. L. Serov
Format: Article
Language:English
Published: Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2022-07-01
Series:Вавиловский журнал генетики и селекции
Subjects:
Online Access:https://vavilov.elpub.ru/jour/article/view/3391
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575095108796416
author N. R. Battulin
O. L. Serov
author_facet N. R. Battulin
O. L. Serov
author_sort N. R. Battulin
collection DOAJ
description Over the past 20 years, coronaviruses have caused three epidemics: SARS-CoV, MERS-CoV, and SARS-CoV2, with the first two having a very high lethality of about 10 and 26 %, respectively. The last outbreak of coronavirus infection caused by SARS-CoV2 in 2019 in China has swept the entire planet and is still spreading. The source of these viruses in humans are animals: bats, Himalayan civets, and camels. The genomes of MERS-CoV, SARS-CoV and SARS-CoV2 are highly similar. It has been established that coronavirus infection (SARS-CoV and SARS-CoV2) occurs through the viral protein S interaction with the lung epithelium – angiotensin-converting enzyme receptor 2 (ACE2) – due to which the virus enters the cells. The most attractive model for studying the development of these diseases is a laboratory mouse, which, however, is resistant to coronavirus infection. The resistance is explained by the difference in the amino acid composition of mouse Ace2 and human ACE2 proteins. Therefore, to create mice susceptible to SARS-CoV and SARS-CoV2 coronaviruses, the human ACE2 gene is transferred into their genome. The exogenous DNA of the constructs is inserted into the recipient genome randomly and with a varying number of copies. Based on this technology, lines of transgenic mice susceptible to intranasal coronavirus infection have been created. In addition, the use of the technology of targeted genome modification using CRISPR/Cas9 made it possible to create lines of transgenic animals with the insertion of the human ACE2 gene under the control of the endogenous murine Ace2 gene promoter. This “humanization” of the Ace2 gene makes it possible to obtain animals susceptible to infection with coronaviruses. Thus, transgenic animals that simulate coronavirus infections and are potential platforms for testing vaccines have now been created.
format Article
id doaj-art-8091b1fc73f044948dcf74ab142e020b
institution Kabale University
issn 2500-3259
language English
publishDate 2022-07-01
publisher Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
record_format Article
series Вавиловский журнал генетики и селекции
spelling doaj-art-8091b1fc73f044948dcf74ab142e020b2025-02-01T09:58:11ZengSiberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and BreedersВавиловский журнал генетики и селекции2500-32592022-07-0126440240810.18699/VJGB-22-491274Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccinesN. R. Battulin0O. L. Serov1Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences; Novosibirsk State UniversityInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences; Novosibirsk State UniversityOver the past 20 years, coronaviruses have caused three epidemics: SARS-CoV, MERS-CoV, and SARS-CoV2, with the first two having a very high lethality of about 10 and 26 %, respectively. The last outbreak of coronavirus infection caused by SARS-CoV2 in 2019 in China has swept the entire planet and is still spreading. The source of these viruses in humans are animals: bats, Himalayan civets, and camels. The genomes of MERS-CoV, SARS-CoV and SARS-CoV2 are highly similar. It has been established that coronavirus infection (SARS-CoV and SARS-CoV2) occurs through the viral protein S interaction with the lung epithelium – angiotensin-converting enzyme receptor 2 (ACE2) – due to which the virus enters the cells. The most attractive model for studying the development of these diseases is a laboratory mouse, which, however, is resistant to coronavirus infection. The resistance is explained by the difference in the amino acid composition of mouse Ace2 and human ACE2 proteins. Therefore, to create mice susceptible to SARS-CoV and SARS-CoV2 coronaviruses, the human ACE2 gene is transferred into their genome. The exogenous DNA of the constructs is inserted into the recipient genome randomly and with a varying number of copies. Based on this technology, lines of transgenic mice susceptible to intranasal coronavirus infection have been created. In addition, the use of the technology of targeted genome modification using CRISPR/Cas9 made it possible to create lines of transgenic animals with the insertion of the human ACE2 gene under the control of the endogenous murine Ace2 gene promoter. This “humanization” of the Ace2 gene makes it possible to obtain animals susceptible to infection with coronaviruses. Thus, transgenic animals that simulate coronavirus infections and are potential platforms for testing vaccines have now been created.https://vavilov.elpub.ru/jour/article/view/3391coronaviruses covssars-covmers-covcovid-19transgenesis“humanization” of the mouse genomecrispr/cas9 technology
spellingShingle N. R. Battulin
O. L. Serov
Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
Вавиловский журнал генетики и селекции
coronaviruses covs
sars-cov
mers-cov
covid-19
transgenesis
“humanization” of the mouse genome
crispr/cas9 technology
title Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
title_full Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
title_fullStr Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
title_full_unstemmed Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
title_short Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines
title_sort creation of transgenic mice susceptible to coronaviruses a platform for studying viral pathogenesis and testing vaccines
topic coronaviruses covs
sars-cov
mers-cov
covid-19
transgenesis
“humanization” of the mouse genome
crispr/cas9 technology
url https://vavilov.elpub.ru/jour/article/view/3391
work_keys_str_mv AT nrbattulin creationoftransgenicmicesusceptibletocoronavirusesaplatformforstudyingviralpathogenesisandtestingvaccines
AT olserov creationoftransgenicmicesusceptibletocoronavirusesaplatformforstudyingviralpathogenesisandtestingvaccines